Health and Economic Impact of a Tender-Based, Sex-Neutral Human Papillomavirus 16/18 Vaccination Program in the Netherlands-Reference-Cited by-同舟云学术

Health and Economic Impact of a Tender-Based, Sex-Neutral Human Papillomavirus 16/18 Vaccination Program in the Netherlands

Published:2017-06-06 Issue:2 Volume:216 Page:210-219
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Qendri Venetia,Bogaards Johannes A,Berkhof Johannes

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/216/2/210/19418290/jix272.pdf

Reference50 articles.

1. Beyond cervical cancer: burden of other HPV-related cancers among men and women;J Adolesc Health,2010

2. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review;BMC Cancer,2012

3. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm;Int J Cancer,2013

4. Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models;PLoS Med,2011

5. Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity;J Infect Dis,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inclusion of marginalized populations in HPV vaccine modeling: A systematic review;Preventive Medicine;2024-05

2. Cost-effectiveness of nonavalent HPV vaccination in the Netherlands;Expert Review of Vaccines;2024-03

3. Knowledge and beliefs of Greek parents towards HPV infection and vaccination – are they willing to vaccinate their sons?;International Journal of Adolescent Medicine and Health;2024-02-02

4. Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in the Netherlands: a data-driven analysis;2023-12-29

5. Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella;PharmacoEconomics;2023-02-21